French animal health company Ceva Santé Animale is nearing the completion of its latest funding round, which could be valued at approximately 9 billion euros ($9.7 billion). This news has garnered attention from both financial investors and professionals in the healthcare sector.

Key Aspects of the Funding Process

According to sources familiar with the situation, Ceva Santé Animale is receiving backing from several major players in the investment market. Téthys Invest SAS, an investment firm owned by the Bettencourt Meyers family, and the Mériers family are poised to increase their stakes. This highlights the rising interest in the company and its potential in the market.

Involvement of New Sponsors

A significant aspect of the current funding round is the participation of new investors, including:

• Archimedes: A French investment company specializing in healthcare, indicating a growing interest in the animal health sector.

• PSP Investments: A Canadian pension fund planning to substantially boost its share in Ceva Santé.

• Temasek Holdings Pte: A Singaporean investment firm that is also actively participating.

These intriguing developments underscore the attractiveness of the animal health sector for investment, particularly given the increasing demand for relevant products and services.

Management Strategy and Control

The management of Ceva Santé, led by CEO Marc Prikazsky, is confidently moving towards maintaining control over the company. They intend to retain a majority of voting rights even after concluding the new round of funding. This strategic decision ensures continued alignment with the company’s goals and vision.

Advantages and Disadvantages of Control Retention Strategy

It is essential to consider both the advantages and limitations of such an approach:

Advantages:

• Protection of the company’s strategic vision;

• Ability to react quickly to changes in the industry;

• Resilience against external pressures.

Disadvantages:

• Limiting opportunities for new investors;

• Risks associated with insufficient funding for scaling.

Prospects and Expectations

Given the current trends in animal health, Ceva Santé Animale has excellent prospects for continued growth. The animal healthcare market has shown steady expansion in recent years, opening new opportunities for active development.

Among the anticipated positive factors are:

• Growing interest in innovative products and services;

• Increase in overall demand for animal health;

• Advancement of modern technologies and solutions in veterinary care.

The funding of Ceva Santé Animale demonstrates a high level of interest from investors and confirms the stable development of the animal health sector. The involvement of significant players like PSP Investments and Temasek Holdings underscores the importance and potential of this field. The strategy of retaining control over the company might also be a crucial factor in avoiding undesirable changes and steering growth in the right direction.